Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study

[1]  E. Tolley,et al.  Acceptability and feasibility of the CHARISMA counseling intervention to support women’s use of pre-exposure prophylaxis: results of a pilot study , 2021, BMC Women's Health.

[2]  Ashley J. Mayo,et al.  Client-Centered Adherence Counseling with Adherence Measurement Feedback to Support Use of the Dapivirine Ring in MTN-025 (The HOPE Study) , 2020, AIDS and Behavior.

[3]  J. Baeten,et al.  Social Harms in Female-INITIATED hiv prevention method RESEARCH: state of the evidence. , 2019, AIDS.

[4]  J. Baeten,et al.  Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial , 2019, AIDS and Behavior.

[5]  E. Tolley,et al.  Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention. , 2019, AIDS education and prevention : official publication of the International Society for AIDS Education.

[6]  T. Palanee-Phillips,et al.  Acceptability and feasibility of CHARISMA: Results of a pilot study addressing relationship dynamics, intimate partner violence and microbicide use , 2018 .

[7]  J. Baeten,et al.  Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial , 2018, Journal of acquired immune deficiency syndromes.

[8]  S. Kapiga,et al.  Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women. , 2016, The New England journal of medicine.

[9]  C. García-Moreno,et al.  Testing a counselling intervention in antenatal care for women experiencing partner violence: a study protocol for a randomized controlled trial in Johannesburg, South Africa , 2016, BMC Health Services Research.

[10]  Ashley J. Mayo,et al.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. , 2016, The New England journal of medicine.

[11]  A. Kharsany,et al.  HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities , 2016, The open AIDS journal.

[12]  S. Karim,et al.  Social Context of Adherence in an Open-Label 1 % Tenofovir Gel Trial: Gender Dynamics and Disclosure in KwaZulu-Natal, South Africa , 2016, AIDS and Behavior.

[13]  Mtn -Aspire Study Team.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women , 2016 .

[14]  A. van der Straten,et al.  Male Partner Influence on Women’s HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of “Understanding” , 2015, AIDS and Behavior.

[15]  B. Friedland,et al.  Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction , 2014, Journal of the International AIDS Society.

[16]  A. van der Straten,et al.  "Male involvement" in women and children's HIV prevention: challenges in definition and interpretation. , 2011, Journal of acquired immune deficiency syndromes.

[17]  A. van der Straten,et al.  The Importance of Male Partner Involvement for Women’s Acceptability and Adherence to Female-Initiated HIV Prevention Methods in Zimbabwe , 2010, AIDS and Behavior.

[18]  R. Jewkes,et al.  Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study , 2010, The Lancet.

[19]  A. van der Straten,et al.  An acceptability and safety study of the Duet® cervical barrier and gel delivery system in Zimbabwe , 2010, Journal of the International AIDS Society.

[20]  A. van der Straten,et al.  Degrees of disclosure: a study of women's covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. , 2009, Social science & medicine.

[21]  R. Jewkes,et al.  Gender and AIDS: time to act. , 2008, AIDS.

[22]  S. Lees,et al.  The role of partnership dynamics in determining the acceptability of condoms and microbicides , 2008, AIDS care.

[23]  C. Watts,et al.  Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence , 2006, The Lancet.

[24]  R. Jewkes,et al.  Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa , 2004, The Lancet.

[25]  L. Ackermann,et al.  SOCIAL FACTORS THAT MAKE SOUTH AFRICAN WOMEN VULNERABLE TO HIV INFECTION , 2002, Health care for women international.

[26]  Z. Stein.  Vaginal microbicides and prevention of HIV infection , 1994, The Lancet.